Wasatch Advisors Inc Biolife Solutions Inc Transaction History

Wasatch Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$32.99 - $58.55 $15.8 Million - $28 Million	-477,463 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$42.03 - $60.5 $27.3 Million - $39.3 Million	-648,803 Reduced 57.61%	477,463 $20.2 Million
Q2 2021 Aug 12, 2021	SELL	$29.51 - $44.62 $183,109 - $276,867	-6,205 Reduced 0.55%	1,126,266 $50.1 Million
Q1 2021 May 10, 2021	SELL	$32.95 - $44.24 $6.71 Million - $9.01 Million	-203,774 Reduced 15.25%	1,132,471 $40.8 Million
Q4 2020 Feb 12, 2021	SELL	$27.5 - $45.75 $10.5 Million - $17.4 Million	-380,670 Reduced 22.17%	1,336,245 $53.3 Million
Q3 2020 Nov 10, 2020	BUY	$16.04 - $28.94 $27.5 Million - $49.7 Million	1,716,915 New	1,716,915 $49.7 Million

198

44.9M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.17B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.